We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$6.16M
Cap. Flow
-$15.9M
Cap. Flow %
-9.4%
Top 10 Hldgs %
30.18%
Holding
221
New
53
Increased
41
Reduced
35
Closed
49

Top Buys

Rank Stock Value
1
CMBM
Cambium Networks
CMBM
+$2.89M
2
INDI icon
indie Semiconductor
INDI
+$2.88M
3
ASPN icon
Aspen Aerogels
ASPN
+$2.86M
4
SCPH
scPharmaceuticals
SCPH
+$2.68M
5
BDSX icon
Biodesix
BDSX
+$2.04M

Top Sells

Rank Stock Value
1
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$7.12M
2
MTRN icon
Materion
MTRN
+$4.81M
3
SEV
Sono Group N.V. Common Shares
SEV
+$2.22M
4
SIMO icon
Silicon Motion
SIMO
+$1.88M
5
TTGT icon
TechTarget
TTGT
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 21.33%
3 Financials 6.11%
4 Industrials 3.63%
5 Real Estate 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVREW
126
SaverOne 2014 Ltd Warrant
SVREW
$48.9K
$14.1K 0.01%
141,364
– –
EXEL icon
127
CALL
Exelixis
EXEL
$13.3B
$14.1K 0.01%
+51,100
New +$833K
INCY icon
128
CALL
Incyte
INCY
$24.2B
$13.9K 0.01%
+44,800
New +$3.43M
HASI icon
129
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
$11.5K 0.01%
+14,900
New +$434K
AXSM icon
130
PUT
Axsome Therapeutics
AXSM
$11.2B
$11K 0.01%
26,200
+12,800
+96% +$765K
GSK icon
131
PUT
GSK
GSK
$104B
$9.12K 0.01%
+52,300
New +$1.74M
INCY icon
132
PUT
Incyte
INCY
$24.2B
$8.32K ﹤0.01%
12,800
-14,000
-52% -$1.07M
AVYA
133
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$6.71K ﹤0.01%
+171,300
New +$191K
IMAX icon
134
PUT
IMAX
IMAX
$2.62B
$5.82K ﹤0.01%
20,000
+9,600
+92% +$140K
APLS
135
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$5.03K ﹤0.01%
+13,400
New +$711K
EXEL icon
136
PUT
Exelixis
EXEL
$13.3B
$5.03K ﹤0.01%
+13,400
New +$219K
MRK icon
137
CALL
Merck
MRK
$322B
$4.67K ﹤0.01%
+6,400
New +$654K
PFE icon
138
CALL
Pfizer
PFE
$143B
$4.1K ﹤0.01%
+44,800
New +$2.15M
IMGN
139
CALL
DELISTED
Immunogen Inc
IMGN
$3.83K ﹤0.01%
+25,500
New +$138K
IMGN
140
PUT
DELISTED
Immunogen Inc
IMGN
$3.19K ﹤0.01%
+63,900
New +$346K
PRBM.WS
141
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$2.78K ﹤0.01%
139,072
– –
ISEE
142
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.01K ﹤0.01%
+13,400
New +$286K
BCS icon
143
PUT
Barclays
BCS
$92.7B
$553 ﹤0.01%
22,100
-4,900
-18% -$35.7K
AAOI icon
144
Applied Optoelectronics
AAOI
$7.57B
– –
-20,000
Closed -$54K
ABBV icon
145
CALL
AbbVie
ABBV
$443B
– –
-26,700
Closed -$10K
ALCO icon
146
Alico
ALCO
$280M
– –
-8,138
Closed -$230K
ALLT icon
147
Allot
ALLT
$372M
– –
-136,062
Closed -$533K
ARDX icon
148
Ardelyx
ARDX
$1.22B
– –
-364,102
Closed -$433K
AVXL icon
149
PUT
Anavex Life Sciences
AVXL
$255M
– –
-13,400
Closed -$7K
BIIB icon
150
PUT
Biogen
BIIB
$30B
– –
-14,800
Closed -$23K
4 5
6
7 8

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Worth Venture Partners held 221 positions worth $169M, up 3.8% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Worth Venture Partners withdrew a net $15.9M in Q4 2022, closing 49 positions and reducing 35 holdings. Its most notable exit was Materion, an estimated $4.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Cambium Networks worth $3.11M.

  • Worth Venture Partners's largest Q4 2022 buy was Cambium Networks: 143,499 shares worth $3.11M.
  • Worth Venture Partners added most to indie Semiconductor in Q4 2022, an estimated $2.88M increase.
  • Worth Venture Partners's biggest Q4 2022 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $7.12M.
  • Worth Venture Partners fully exited Materion in Q4 2022, selling an estimated $4.81M.
  • Worth Venture Partners's ten largest holdings make up 30% of its $169M portfolio in Q4 2022.
  • Worth Venture Partners opened 53 new positions and closed 49 in Q4 2022.
  • Worth Venture Partners's portfolio value rose 3.8% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q4 2022, filed 14 Feb 2023.